Supplier profile
GENESIS PHARMA (CYPRUS) LTD
Every public-sector award we hold for this supplier, across Cyprus, from 11 Feb 2009 to 23 Sept 2026.
Awards won
118
all time
Attributed value
€168.2m
12 shared, unvalued
Buyers
5
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Υπουργείο Υγείας | 63 | €120.7m |
| Φαρμακευτικές Υπηρεσίες | 47 | €41.3m |
| Υπουργείο Υγείας; Φαρμακευτικές Υπηρεσίες | 6 | €5.3m |
| Υπουργείο Υγείας; Φαρμακευτικές Υπηρεσίες. | 1 | €773k |
| Φαρμακευτικές υπηρεσίες | 1 | €170k |
What they win
Awards
Showing 26–50 of 118 awards we hold
- Cyprus-Nicosia: Antineoplastic agents ↗Υπουργείο Υγείας€587kawarded 10 Feb 2023
- Cyprus-Nicosia: Medicinal products for the musculo-skeletal system ↗Υπουργείο Υγείας€3.5mawarded 21 Nov 2022
- Cyprus-Nicosia: Antineoplastic agents ↗Υπουργείο Υγείας€1.4mawarded 11 Oct 2022
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείαςshared awardawarded 23 Sept 2022
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείαςshared awardawarded 8 Aug 2022
- Cyprus-Nicosia: Medicinal products for the nervous system ↗Υπουργείο Υγείας€3.7mawarded 1 Jul 2022
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείας€828kawarded 1 Apr 2022
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείας€936kawarded 1 Apr 2022
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείας€3.1mawarded 28 Feb 2022
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείας€2.2mawarded 16 Feb 2022
- Cyprus-Nicosia: Medicinal products for the nervous system ↗Υπουργείο Υγείας€7.8mawarded 16 Feb 2022
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείαςshared awardawarded 11 Feb 2022
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείας€79kawarded 1 Oct 2021
- Cyprus-Nicosia: Medicinal products for the musculo-skeletal system ↗Υπουργείο Υγείας€1.7mawarded 17 Aug 2021
- Cyprus-Nicosia: Medicinal products for the nervous system ↗Υπουργείο Υγείας€255kawarded 9 Jun 2021
- Cyprus-Nicosia: Antineoplastic agents ↗Υπουργείο Υγείας€123kawarded 19 May 2021
- Cyprus-Nicosia: Medicinal products for the nervous system ↗Υπουργείο Υγείας€1.8mawarded 12 May 2021
- Cyprus-Nicosia: Medicinal products for the nervous system ↗Υπουργείο Υγείας€1.6mawarded 7 May 2021
- Cyprus-Nicosia: Immunosuppressive agents ↗Υπουργείο Υγείας€1.9mawarded 19 Mar 2021
- Cyprus-Nicosia: Medicinal products for the nervous system ↗Υπουργείο Υγείας€611kawarded 31 Dec 2020
- Cyprus-Nicosia: Medicinal products for the nervous system ↗Υπουργείο Υγείας€408kawarded 25 Sept 2020
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείας€1.7mawarded 17 Apr 2020
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείας€2.3mawarded 14 Feb 2020
- Cyprus-Nicosia: Immunosuppressive agents ↗Υπουργείο Υγείαςshared awardawarded 10 Feb 2020
- Cyprus-Nicosia: Antineoplastic and immunomodulating agents ↗Υπουργείο Υγείας€2.2mawarded 27 Dec 2019
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative. Profiles may take up to an hour to reflect newly collected records.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.